Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Serina Therapeutics (SER) over the last 8 years, with Q3 2025 value amounting to -$0.45.

  • Serina Therapeutics' EPS (Basic) fell 38125.0% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.87, marking a year-over-year increase of 5536.99%. This contributed to the annual value of -$2.39 for FY2024, which is 20119.05% down from last year.
  • Per Serina Therapeutics' latest filing, its EPS (Basic) stood at -$0.45 for Q3 2025, which was down 38125.0% from -$0.66 recorded in Q2 2025.
  • In the past 5 years, Serina Therapeutics' EPS (Basic) registered a high of $0.8 during Q3 2023, and its lowest value of -$9.5 during Q4 2022.
  • Over the past 5 years, Serina Therapeutics' median EPS (Basic) value was -$0.06 (recorded in 2021), while the average stood at -$0.77.
  • In the last 5 years, Serina Therapeutics' EPS (Basic) tumbled by 1573333.33% in 2022 and then skyrocketed by 143333.33% in 2023.
  • Quarter analysis of 5 years shows Serina Therapeutics' EPS (Basic) stood at -$0.06 in 2021, then crashed by 15733.33% to -$9.5 in 2022, then soared by 104.42% to $0.42 in 2023, then tumbled by 280.08% to -$0.76 in 2024, then soared by 40.5% to -$0.45 in 2025.
  • Its last three reported values are -$0.45 in Q3 2025, -$0.66 for Q2 2025, and -$0.49 during Q1 2025.